7 maio 2020 ano - RCT (Preprint) - HCQ in patients with
mild to moderate COVID–19
Descrição:
"The results of our trial did not show additional benefits of virus elimination by adding HCQ to the current SOC in patients mainly with persistent mild to moderate COVID–19." [26]
Adicionado na linha do tempo:
Data: